Hepatitis C Genotype 1 Cured With 4 Weeks of Pegylated Interferon, Ribavirin, and Sofosbuvir

被引：0
|
作者：
Habibullah, Masud [1 ]
Bunim, Ari [1 ]
Rubin, Moshe [1 ]
机构：
[1] New York Hosp Queens, Flushing, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2014年 / 109卷
关键词：
D O I：
10.14309/00000434-201410002-00519
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
519
引用
收藏
页码：S153 / S153
页数：1
相关论文
共 50 条
  • [31] Chronic hepatitis C genotype 6 responds better to pegylated interferon and ribavirin combination therapy than genotype 1
    Tsang, Owen T-Y
    Zee, Jonpaul S-T
    Chan, Jacky M-C
    Li, Reggie S-T
    Kan, Yee-Man
    Li, Francis T-W
    Lo, Fu-Hang
    Chow, David A.
    Cheung, Kent W-L
    Chan, Kam-Hon
    Yeung, Yat-Wah
    Ng, Fook-Hong
    Li, Michael K-K
    Kwan, Wai-Keung
    Lai, Thomas S-T
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (04) : 766 - 771
  • [32] A randomized trial of 48 versus 24 weeks of combination pegylated interferon and ribavirin therapy in genotype 6 chronic hepatitis C
    Pham Thi Thu Thuy
    Bunchorntavakul, Chalermrat
    Ho Tan Dat
    Reddy, K. Rajender
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 (05) : 1012 - 1018
  • [33] Chronic hepatitis C virus genotype 6 infection: Response to pegylated interferon and ribavirin
    Fung, James
    Lai, Ching-Lung
    Hung, Ivan
    Young, John
    Cheng, Charles
    Wong, Danny
    Yuen, Man-Fung
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (06): : 808 - 812
  • [34] Treatment of hepatitis C virus genotype 2 and 3 with pegylated interferon plus ribavirin
    Rizzetto, M
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 (02) : 275 - 276
  • [35] Prediction of nonSVR to therapy with pegylated interferon-α2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment
    Lukasiewicz, E.
    Gorfine, M.
    Freedman, L. S.
    Pawlotsky, J. -M.
    Schalm, S. W.
    Ferrari, C.
    Zeuzem, S.
    Neumann, A. U.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2010, 17 (05) : 345 - 351
  • [36] Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4
    Doss, Wahid
    Shiha, Gamal
    Hassany, Mohamed
    Soliman, Reham
    Fouad, Rabab
    Khairy, Marwa
    Samir, Waleed
    Hammad, Radi
    Kersey, Kathryn
    Jiang, Deyuan
    Doehle, Brian
    Knox, Steven J.
    Massetto, Benedetta
    McHutchison, John G.
    Esmat, Gamal
    [J]. JOURNAL OF HEPATOLOGY, 2015, 63 (03) : 581 - 585
  • [37] Nitazoxanide plus pegylated interferon and ribavirin in the treatment of genotype 4 chronic hepatitis C, a randomized controlled trial
    Shehab, Hany M.
    Elbaz, Tamer M.
    Deraz, Dalia M.
    [J]. LIVER INTERNATIONAL, 2014, 34 (02) : 259 - 265
  • [38] Cost Analysis of Sofosbuvir/Ribavirin Versus Sofosbuvir/Simeprevir for Genotype 1 Hepatitis C Virus in Interferon-Ineligible/Intolerant Individuals
    Hagan, Liesl M.
    Sulkowski, Mark S.
    Schinazi, Raymond F.
    [J]. HEPATOLOGY, 2014, 60 (01) : 37 - 45
  • [39] 100% SVR12 WITH LEDIPASVIR/SOFOSBUVIR±RIBAVIRIN FOR 12 WEEKS IN JAPANESE PATIENTS WITH CHRONIC GENOTYPE 1 HEPATITIS C VIRUS WHO PREVIOUSLY FAILED THERAPY WITH PROTEASE INHIBITOR plus PEGYLATED INTERFERONα plus RIBAVIRIN
    Omata, M.
    Takehara, T.
    Yokosuka, O.
    Sakamoto, N.
    Korenagai, M.
    Mochizuki, H.
    Nakane, K.
    Enomoto, H.
    Yanase, M.
    Toyoda, H.
    Ikeda, F.
    Genda, T.
    Umemura, T.
    Yatsuhashi, H.
    Ide, T.
    Toda, N.
    Nirei, K.
    Ueno, Y.
    Nishigaki, Y.
    De-Oertel, S.
    Gao, B.
    Dvory-Sobol, H.
    Ishizaki, A.
    Omote, M.
    Pang, P. S.
    Knox, S. J.
    Symonds, W. T.
    McHutchison, J. G.
    Izumi, N.
    Mizokami, M.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S626 - S627
  • [40] Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4
    Jose Urquijo, Juan
    Diago, Moises
    Boadas, Jaume
    Planas, Ramon
    Sola, Ricard
    Angel del Olmo, Juan
    Crespo, Javier
    Carlos Erdozain, Jose
    Dolores Anton, Maria
    Arocena, Carlos
    Suarez, Dolores
    Gine, Josep
    Barrera, Josep M.
    Garcia-Samaniego, Javier
    Perez, Ricardo
    Dalmau, Blai
    Montoro, Miguel
    [J]. ANNALS OF HEPATOLOGY, 2013, 12 (01) : 30 - 35
12345